In honor of National Ovarian Cancer Month and Gynecologic Cancer Month, both taking place in September, Walgreens and Ferring Pharmaceuticals Inc. today announced a collaboration to provide free access to certain fertility medications and educational resources as part of Ferring's h.e.a.r.t. BEAT program. The program is a patient assistance initiative funded by Ferring and provided as a public service to eligible women of reproductive age who have received a new cancer diagnosis and wish to undergo fertility preservation prior to the start of their cancer treatment.
There are no financial requirements or applications to complete. Patients must be:
- U.S. citizen or permanent resident
- Diagnosis of cancer
- Cancer treatment has not been initiated
- No recent chemotherapy treatment within prior six months
- Oncologist and Reproductive Endocrinologist determine that Fertility Preservation treatment is medically appropriate
The fertility medications, manufactured by Ferring Pharmaceuticals Inc., included in the h.e.a.r.t. BEAT progam are BRAVELLE®, MENOPUR® and NOVAREL®. Physicians may call Walgreens Specialty Pharmacy at 888-347-3415 with a verbal prescription and the medication will be shipped via UPS to either the physician's office or the patient. No completion of forms is required.